secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turnstone Biologics Corp. (—)
CIK:        0001764974
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001193125-23-193445
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Turnstone Biologics adopts amended charter and bylaws effective upon IPO closing
--------------------------------------------------------------------------------

- Filed amended and restated certificate of incorporation with Delaware Secretary of State on July 25, 2023.
- Adopted amended and restated bylaws effective immediately prior to IPO closing on same date.
- Both documents were previously approved by board and stockholders in connection with the IPO.
- Company's common stock trades on Nasdaq under ticker TSBX as an emerging growth company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764974/000119312523193445/0001193125-23-193445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764974/000119312523193445/d878456d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-193445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer